In a statement released yesterday, the commissioner of the Food and Drug Administration, Scott Gottlieb, MD, shared an encouraging update related to the ongoing shortage of IV fluids.
“Based on the information we’re receiving from companies and the actions we’ve taken at the FDA, we continue to expect that the shortage of IV fluids will improve in the coming weeks and months,” said Gottlieb. However, he added a caution: “Despite these steps, it may still take more time for new product supply to diffuse across the marketplace and have a noticeable impact on product availability.”
Please click here to read the full update.
